
Oil tycoon Wilmer Ruperti showed up for a meeting with Venezuela’s intelligence agency last Thursday. A week later, he’s still in custody, one of his lawyers told Semafor.
“We’ve reached out to everybody trying to get proof of life or some support,” Winston & Strawn’s Cari Stinebower said, adding that officials still haven’t conveyed “how he’s being treated or why he’s being detained.”
Ruperti, who arrived at the meeting with a security detail, is a Venezuelan Italian shipping magnate who trades in petroleum coke. His detainment followed interim President Delcy Rodríguez’s decision to elevate the agency’s longtime chief to defense minister.
“The message is that Venezuela is open for business — but detaining businessmen for days on end without any due process or access to counsel is more old regime,” Stinebower said. “This is not law and order and not conducive of a welcoming business environment.”
The State Department and Energy Department did not respond to requests for comment.
LATEST POSTS
- 1
Artemis 2 captures historic 'Earthset' photo | Space photo of the day for April 7, 2026 - 2
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds - 3
Fireballs and a full moon. Here’s how to see two celestial events this week - 4
Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos - 5
Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
Volkswagen Just Revealed a Massive Range-Extended SUV for China, and America Isn’t Getting It
Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
Find the Standards of Powerful Cooperation: Accomplishing Cooperative energy and Coordinated effort
A hunger for new experiences Narratives: Motivating Travel and Experience
Portugal among EU countries with the most people working close to 50 hours a week
Become the best at Discussion: 6 Procedures for Progress
Is 'Veronica Mars' about to be your new binge-watch? It's now streaming on Netflix.
Consumer experts: German petrol hikes rule won't bring down prices
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump












